ClinicalTrials.gg
Status unknownNCT04916041Updated Jul 20, 2022

Visual Function in Subjects Implanted With Advanced Technology Intraocular Lenses

An observational study in Lenses, Intraocular, sponsored by Clínica Rementería. Status unknown at 1 site in Spain. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-07-20.

Sponsored by Clínica Rementería · Observational

How we know

The sponsor has not verified this record recently (last verified Jul 2022), so the status shown — last known as Recruiting — may be out of date.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
150
Ages
18 Years and older
Sex
All
01

Study summary

Multiple intraocular lens are nowadays available for implantation after cataract surgery. They use different technology to try to improve patient spectacle independence. It is necessary to better characterise the performence of each type of lens, as well as to define how they are affected by residual refractive errors. The purpose of this study is to evaluate visual function in patients implanted with different lenses (advanced monofocals, trifocals) in order to be able to recommend the best type of lens for each patient.

02

Conditions studied

  • Lenses, Intraocular
03

In context

Lead sponsor

Clínica Rementería is the lead sponsor of 5 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients who have undergone bilateral cataract surgery between three and nine months prior to study procedures, with bilateral implantation of one of the intraocular lens models included in the study

Eligibility criteria

Inclusion Criteria: Bilateral cataract surgery Bilateral implantation of one of the intraocular lens models included in the study

Exclusion Criteria:

Intrasurgical complications Postsurgical complications Ophthalmological disease that limits visual potential as estimated by investigator

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
150 participants (estimated)
Patient registry
No

Groups and cohorts

  • Vivity

    Patients who have undergone bilateral implantation of Vivity intraocular lens

    Device: Cataract surgery with bilateral implantation of the same type of intraocular lens

  • Eyhance

    Patients who have received bilateral implantation of an Eyhance intraocular lens

    Device: Cataract surgery with bilateral implantation of the same type of intraocular lens

  • EMV

    Patients who have undergone bilateral implantation of Vivity intraocular lens

    Device: Cataract surgery with bilateral implantation of the same type of intraocular lens

  • Panoptix

    Patients who have undergone bilateral implantation of Panoptix intraocular lens

    Device: Cataract surgery with bilateral implantation of the same type of intraocular lens

  • Rayner Trifocal

    Patients who have undergone bilateral implantation of Rayner trifocal intraocular lens

    Device: Cataract surgery with bilateral implantation of the same type of intraocular lens

Interventions

  • DeviceCataract surgery with bilateral implantation of the same type of intraocular lens

    Cataract surgery with bilateral implantation of the same type of intraocular lens

06

What researchers measure

Primary outcomes

  1. Intermediate binocular uncorrected visual acuity

    Time frame: 3-9 months after cataract surgery

Secondary outcomes

  1. Distance binocular uncorrected visual acuity

    Time frame: 3-9 months after cataract surgery

  2. Near binocular uncorrected visual acuity

    Time frame: 3-9 months after cataract surgery

  3. Binocular contrast sensitivity

    Time frame: 3-9 months after cataract surgery

  4. Halo perception

    Time frame: 3-9 months after cataract surgery

  5. Self-reported visual function questionnaires

    Time frame: 3-9 months after cataract surgery

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jun 2021 (actual). Primary completion is estimated for Jun 2023, 24 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 1, 2021
First posted
Jun 7, 2021
StartActual
Jun 1, 2021
Primary completionEst.
Jun 1, 2023
CompletionEst.
Sep 1, 2023
Last update
Jul 20, 2022
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 20, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04916041
Lead sponsor
Clínica Rementería
Responsible party
Sponsor
First posted
Jun 7, 2021
Start date
Jun 1, 2021
Primary completion
Jun 1, 2023 (estimated)
Completion
Sep 1, 2023 (estimated)
Last update
Jul 20, 2022

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jul 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion